Anavaj Shakuntabai

Title: Anavaj Shakuntabai: Innovator in Dengue Virus Research

Introduction

Anavaj Shakuntabai is a notable inventor based in Paris, France. He has made significant contributions to the field of virology, particularly in the development of immunogenic compositions against dengue virus infection. His innovative work has the potential to impact public health positively.

Latest Patents

Anavaj Shakuntabai holds a patent for a "Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection." This invention focuses on a chimeric polyepitope that includes fragments of non-structural proteins. It provides methods and means, including polynucleotides, vectors, and cells, to produce vectors expressing these chimeric polyepitopes. Notably, the invention utilizes recombinant measles virus (MV) particles for the prevention and treatment of dengue virus infection. He has 1 patent to his name.

Career Highlights

Anavaj has worked with prestigious institutions such as Institut Pasteur and Institut Pasteur du Cambodge. His work at these organizations has allowed him to collaborate with leading experts in the field of infectious diseases.

Collaborations

Some of his notable coworkers include Frederic Tangy and Etienne Simon-Loriere. Their collaborative efforts have contributed to advancing research in dengue virus and other infectious diseases.

Conclusion

Anavaj Shakuntabai's innovative research and patent in dengue virus immunogenic compositions highlight his significant role in the scientific community. His contributions are vital for the ongoing fight against dengue virus infections.